Specialty pharmacy's next decade: 3 key insights
The specialty pharmacy sector is changing due to new drugs, payer strategies, and rising competition. This white paper presents three future changes for specialty pharmacy business models:
-
Pharmacies will adjust operations to handle more biosimilars, generics, and rare disease drugs, affecting revenue and capabilities.
-
They'll explore value-based partnerships with payers to navigate benefit changes and prove cost-effective, quality care.
-
To outdo competitors like PBM and health system pharmacies, they'll enhance patient experiences, leverage data for quality care, and cut costs.
Discover more on specialty pharmacy's future in the full white paper.